[Acne vulgaris as a therapeutic problem]. 1999

L Brzezińska-Wcisło
I Katedry i Kliniki Dermatologii Slaskiej Akademii Medycznej w Katowicach.

Acne vulgaris, the most frequent skin disease of adolescence, because of its location, particularly long lasting course and in, case of some patients, leaving deformations in a form of scars can lead to disturbances in the psychosocial sphere. Medications used in the topical and systemic therapy of acne should reveal such proportions as: anti-seborrhoeic, bactericidal, bacteriostatic, antiphogistic, comedoleitis, anti-comedoformative. Both, in the topical and systemic therapy of acne vulgaris antibiotics such as tetracyclines, erythromycin and clindamycin are used. Other medicaments prescribed for the topical therapy of acne are azelaic acid and benzoil peroxide, retinoic acid--tretinoin and 13-cis-Retinoic acid--isotretinoin. Isotretinoin--13-cis-Retinoic acid used in the systemic therapy is the most potent drug--treating acne which has not reacted to any conventional methods of therapy.

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000152 Acne Vulgaris A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. Acne
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

L Brzezińska-Wcisło
August 1968, Zeitschrift fur Haut- und Geschlechtskrankheiten,
L Brzezińska-Wcisło
August 1965, Canadian Medical Association journal,
L Brzezińska-Wcisło
August 1965, Canadian Medical Association journal,
L Brzezińska-Wcisło
January 1978, Actas dermo-sifiliograficas,
L Brzezińska-Wcisło
January 2013, Nursing times,
L Brzezińska-Wcisło
May 1998, Medizinische Monatsschrift fur Pharmazeuten,
L Brzezińska-Wcisło
January 1959, Antibiotic medicine & clinical therapy (New York, NY),
L Brzezińska-Wcisło
January 2000, The American journal of managed care,
L Brzezińska-Wcisło
July 1957, Zeitschrift fur Haut- und Geschlechtskrankheiten,
L Brzezińska-Wcisło
February 1962, Wisconsin medical journal,
Copied contents to your clipboard!